Mario Schlosser Sells 6,516 Shares of Oscar Health, Inc. (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) insider Mario Schlosser sold 6,516 shares of the company’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total value of $117,809.28. Following the completion of the sale, the insider now owns 81,962 shares in the company, valued at $1,481,872.96. This trade represents a 7.36 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Oscar Health Trading Down 5.7 %

NYSE OSCR opened at $16.96 on Thursday. The firm has a market cap of $4.19 billion, a P/E ratio of -282.62 and a beta of 1.63. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The stock’s 50-day moving average is $17.18 and its 200-day moving average is $17.94. Oscar Health, Inc. has a one year low of $7.50 and a one year high of $23.79.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). The company had revenue of $2.42 billion during the quarter, compared to the consensus estimate of $2.33 billion. Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The firm’s revenue for the quarter was up 68.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.29) earnings per share. Sell-side analysts anticipate that Oscar Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Oscar Health

Several hedge funds and other institutional investors have recently added to or reduced their stakes in OSCR. Neo Ivy Capital Management acquired a new position in shares of Oscar Health during the 3rd quarter worth $600,000. Geode Capital Management LLC grew its position in shares of Oscar Health by 11.7% in the 3rd quarter. Geode Capital Management LLC now owns 4,339,640 shares of the company’s stock valued at $92,062,000 after buying an additional 455,205 shares during the last quarter. Barclays PLC boosted its position in shares of Oscar Health by 217.5% during the 3rd quarter. Barclays PLC now owns 325,818 shares of the company’s stock valued at $6,911,000 after purchasing an additional 223,189 shares in the last quarter. Y Intercept Hong Kong Ltd bought a new stake in shares of Oscar Health during the 3rd quarter valued at about $2,764,000. Finally, Soros Fund Management LLC bought a new stake in shares of Oscar Health during the 3rd quarter valued at about $12,726,000. 75.70% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on OSCR. Bank of America cut Oscar Health from a “neutral” rating to an “underperform” rating and lowered their price target for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. UBS Group assumed coverage on Oscar Health in a research report on Monday, October 7th. They issued a “neutral” rating and a $23.00 price target on the stock. Finally, Piper Sandler reiterated an “overweight” rating and issued a $28.00 price target on shares of Oscar Health in a report on Tuesday, September 10th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $22.93.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.